AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
DIOSMINE
15 registrations across 5 African markets— 13 active
Markets with DIOSMINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| DIOVENOR 600MG COMPRIME PELLICULE BOITE DE 30 | 🇨🇮Côte d'Ivoire | LABORATOIRE INNOTECH INTERNATIONAL | active | Aug 2026 |
| DIOGAM Comprimé pelliculé sécable / 600 MG | 🇹🇳Tunisia | PHARMAGHREB | expired | Jan 2009 |
| DIOGAM Comprimé pelliculé / 300 MG | 🇹🇳Tunisia | PHARMAGHREB | expired | May 2004 |
| DIOVENOR COMPRIME PELLICULE | 🇲🇦Morocco | — | active | — |
| MEDIVEINE COMPRIME PELLICULE | 🇲🇦Morocco | — | active | — |
| DIOVENOR comprimé / 600 mg | 🇸🇳Senegal | INNOTECH INTERNATIONAL | active | — |
| MEDIVEINE COMPRIME PELLICULE | 🇲🇦Morocco | — | active | — |
| DIOVENOR COMPRIME PELLICULE | 🇲🇦Morocco | — | active | — |
| DIOVENOR 600MG COMPRIME PELLICULE BOITE DE 15 | 🇨🇮Côte d'Ivoire | LABORATOIRE INNOTECH INTERNATIONAL | active | — |
| MEDIVEINE comprimé / 600mg | 🇸🇳Senegal | SOTHEMA | active | — |
| DIOVENOR comprimé / 600 mg | 🇸🇳Senegal | INNOTHERA | active | — |
| DIOVENOR 600 CP PELL BTE (2X15) LABORATOIRES INNOTHERA comprimé pelliculé, boîte de | 🇲🇬Madagascar | LABORATOIRES INNOTHERA | active | — |
| VENOSMINE FORTE comprimé / 450 mg | 🇸🇳Senegal | GEYMONAT | active | — |
| DIOVENOR 600 CP PELL BTE (2X15) LABORATOIRES INNOTHERA comprimé pelliculé, boîte de | 🇲🇬Madagascar | LABORATOIRES INNOTHERA | active | — |
| MEDIVEINE COMPRIME PELLICULE | 🇲🇦Morocco | — | active | — |
DIOSMINE in Africa — Regulatory Overview
DIOSMINE is registered across 5 African markets with 15 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Morocco, Senegal, Côte d'Ivoire, Madagascar and 1 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 15 registrations, 13 (87%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.